FDA 483 - Family Pharmacy of Statesville - March 11, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Family Pharmacy of Statesville, Inc. revealed multiple critical deficiencies in aseptic processing and environmental controls for sterile drug production. Observations included inadequate material handling, insufficient disinfection practices, and failures in media fill simulations to challenge aseptic operations. The facility also lacked proper HEPA filtration, failed to verify sterilization cycles, and exhibited poor cleanroom design and maintenance, indicating a significant risk of contamination to sterile products.
ID · 6f86481d-1b8b-48f7-8bcc-f118b686f840